BenchSci, specializing in artificial intelligence for preclinical research, has entered into a strategic partnership with Thermo Fisher Scientific, one of the largest providers of laboratory instruments and reagents. The collaboration is intended to integrate BenchSci’s ASCEND™ AI platform with Thermo Fisher’s scientific tools to accelerate experimental design and improve research productivity.
BenchSci’s technology acts as an AI assistant for scientists, leveraging a proprietary biomedical knowledge graph and machine learning models to decode scientific evidence and uncover biological insights. This partnership will expand what’s possible for researchers everywhere. Pairing our AI expertise with Thermo Fisher’s footprint of lab equipment, consumables, and services will create new opportunities for scientists across the life sciences ecosystem.
Liran Belenzon, CEO and co-founder of BenchSci
According to the companies, the partnership will focus on developing AI-driven software to support several stages of the research workflow. Planned applications include systems to enhance the interpretation of large experimental datasets, web-based tools for mining the scientific literature, and algorithms to guide the selection of optimal reagents. By embedding these AI-enabled capabilities into Thermo Fisher’s instruments and digital platforms, the firms aim to help scientists refine experimental design, reduce inefficiencies, and make better use of laboratory resources.
AI is unlocking a new era of scientific possibility, and our partnership with BenchSci will help our customers accelerate their important work. By combining our global scale, world-class products, and innovation leadership with BenchSci’s advanced AI capabilities, we will transform our customers’ capabilities to model science in silico, enabling them to move from scientific ideas to approved medicines faster and more cost-effectively.
Gianluca Pettiti, executive vice president and president, Life Sciences, Diagnostics and Applied at Thermo Fisher Scientific.